|
|
Article: Canadian Bio Med Systems Inc., appoints Dr. George Tsoukas as Medical Director.
- Article from:
- Clinical Trials Week
- Article date:
- November 16, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Canadian Bio Med Systems Inc., a subsidiary of ICBS Ltd., (OTCPK: ICBT), and Ocular Therapeutics Inc., of San Diego California, announced that Dr George Tsoukas, M.D. has agreed to become Medical Director of Canadian Bio Med Systems Inc (see also Inter Canadian Business Service).
Dr. George Tsoukas of Montreal, has been appointed Medical director to oversee the testing and clinical trials for the new drug, LD22-4 which treats Age-Related Macular Degeneration of the eye. Endocrinologist, Associate Professor, McGill University Health Center, Montreal, Quebec, Dr. Tsoukas, a noted physician and educator, is a physician at the McGill University Medical Center in ...